top of page


Thursday, April 4, 2024

11:00 AM    

Registration Opens

1:00 PM – 1:05 PM             

Zobair Younossi, MD, MPH


1:05 PM – 1:30 PM            
Willis C. Maddrey Distinguished Lecture on Alcohol Liver Disease           

Keynote Speaker: Mack Mitchell, MD

Introduction: Steven Flamm, MD  


Session I: Alcohol Liver Disease

1:30 PM – 2:30 PM

Co-moderators: Steven Flamm, MD; and Mack Mitchell, MD


Management of Alcohol Associated Hepatitis

Craig McClain, MD

Liver Transplantation: More Than Surgery

Brian Lee, MD

Q&A/Panel Discussion

2:30 PM – 3:00 PM             


Session II: Cirrhosis

3:00 PM – 4:30 PM 

Session Co-chairs: Marcelo Kugelmas, MD; and Sammy Saab, MD, MPH

Case I: Obese Patient with NASH Cirrhosis

Panelists: Nadege Gunn, MD, Prasun Jalal, MD, Hetal Karsan, MD, and Parvez Mantry, MD

Case II: Refractory HE

Panelists: Chathur Acharya, MD, Frederic Gordon, MD, Nancy Reau, MD, and Vinod Rustgi, MD

Case III: Surgical Risk Stratification

Panelists: Ray Kim, MD, Edward Mena, MD, Santiago Munoz, MD, and Nikolaos Pyrsopoulos, MD

4:30 PM             

Day 1 Wrap-up

5:30 PM – 6:00 PM             

Industry Forum Block

6:15 PM – 7:00 PM         

Industry-Sponsored Event (Non-Accredited)


7:00 PM – 9:00 PM             
CLDF & Top Sponsor Reception

Friday, April 5, 2024

7:00 AM             

Registration & Breakfast


7:15 AM – 8:00 AM            

Industry-Sponsored Event (Non-Accredited) 

8:00 AM – 8:30 AM            



8:30 AM – 8:35 AM            

Welcome Back

Zobair Younossi, MD, MPH


Session III: NASH

8:35 AM – 10:10 AM 

Co-moderators: Alina Allen, MD; and Zobair Younossi, MD, MPH


The Continuum of Disease: Rethinking the Existing Categories and Stages

Alina Allen, MD


Use of Surrogate Markers and Algorithms to Identify High-Risk Patients and Optimize Outcomes

Rohit Loomba, MD, MHSc


New Data on Lifestyle Recommendations and Treatments on the Horizon

Manal Abdelmalek, MD, MPH

Role of Non-hepatologists in the Management of Patients with NASH/MASLD     

Kenneth Cusi, MD 

10:10 AM – 10:30 AM         



Session IV: HCC

10:30 AM – 12:00 PM   

Co-moderators: Aijaz Ahmed, MD; and Robert Wong MD, MS 


What's In and What's Out: Highlights and Takeaways from Updated AASLD HCC Practice Guidelines

Laura Kulik, MD


Mock Tumor Board Case 1: Weighing the Options of Surgery vs. Transplant

Neil Mehta, MD


Mock Tumor Board Case 2: Selecting the Best Treatment for Inoperable HCC

Richard Finn, MD


Panel Discussion & Session Summary

12:00 PM       

Day 2 Wrap-up

12:00 PM – 12:30 PM         

Lunch Break


12:30 PM – 1:15 PM           

Industry-Sponsored Event (Non-Accredited)

1:30 PM – 3:45 PM


HBV Workshop

Co-chairs: Robert Gish, MD; and Ira Jacobson, MD

1:30 - 1:50 PM

Epigenetic Modifiers and Gene Therapy

Fabien Zoulim, MD, PhD (Virtual) 

1:50 - 2:10 PM
HBV Virology: Integration, New Biomarkers

Ju-Tao Guo, MD (Virtual) 

2:10 - 2:30 PM
New Insights into HBV Immunology

Kyong-Mi Chang, MD 

2:30 - 2:50 PM
Key Takeaways from siRNA and ASO Stud

Mark Sulkowski, MD 

2:50 - 3:05 PM
CAMs: How Do They Work? Do They Have a Future Role?

Man Fung Yuen, MD, PhD, DSc (Virtual)

3:05 - 3:20 PM
Q&A/Panel Discussion

3:20 - 3:35 PM

3:35 - 3:55 PM
What Are the Most Promising Immune-Based Therapies for HBV?

Patrick Kennedy, MB BCh BAO BMedSci FRCP MD (Virtual)

3:55 - 4:15 PM

HBV Treatment: The Current Landscape (Whom to Treat, Who Can Stop)

Ira Jacobson, MD

4:15 - 4:35 PM
HDV Year in Review: EASL, HDV Cure, AASLD, HepDart

Robert Gish, MD 

4:35 - 4:55 PM
Bulevirtide: Lessons for Treatment from Real-World Studies

Nancy Reau, MD 

4:55 - 5:10 PM
Q&A/Panel Discussion

5:10 PM 

Closing Remarks 

Pediatric Liver Disease MASLD Workshop

Co-chairs: Carina Kugelmas, MD; and Miriam Vos, MD, MSPH


Co-Chairs: Carina Kugelmas, MD and Miriam Vos, MD, MSPH

1:30 – 1:35 PM

Welcome and Introduction

Session I

Co-moderators: Rima Fawaz, MD; and Miriam Vos, MD, MSPH


1:35 - 1:50 PM

Clustering of Metabolic Diseases and MASLD

Nicola Santoro, MD, PhD

1:50 - 2:05 PM

Are We Ready to Screen with a Genetic Panel in Pediatric MASLD?

Nidhi Goyal, MD

2:05 - 2:20 PM

The Name Changed—Now What?

Jeffrey Schwimmer, MD


2:20 - 2:40 PM

Panel Discussion: Diagnosing Steatosis in Children and Consequences of the Name Change (MASLD)

Nidhi Goyal, MD; Nikhil Pai, MD; Nicola Santoro, MD, PhD; Jeffrey Schwimmer, MD; and Stavra A. Xanthakos, MD, MS

Session II

Co-moderators: Carina Kugelmas, MD and Shikha Sundaram, MD


2:40 – 2:55 PM

New Therapies for Treating Obesity Beyond Diet: AOMs and Bariatric Surgery

Stavra Xanthakos, MD, MS


2:55 - 3:10 PM


Melanie Cree, MD

3:10 - 3:20 PM

Using Metformin for MASLD

Miriam Vos, MD, MSPH

3:20 – 3:40 PM

Panel Discussion, Cases, and Q&A

Melanie Cree, MD; Rima Fawaz, MD; Rohit Kohli, MBA, MS; Jeffrey Schwimmer, MD; and Miriam Vos, MD, MSPH

3:40 - 3:45 PM

Closing Remarks

4:00 PM – 5:00 PM

GI & Hepatology Fellows Networking Reception


5:15 PM – 6:00 PM

Industry-Sponsored Event (Non-Accredited)

6:00 PM – 8:00 PM             

Conference Reception

Saturday, April 6, 2024

7:00 AM            

Registration & Breakfast


7:15 AM – 8:00 AM            

Industry-Sponsored Event (Non-Accredited)


8:00 AM – 8:30 AM            


8:30 AM – 8:35 AM            

Welcome Back


Session V: Autoimmune Cholestatic Liver Disease

8:35 AM – 10:00 AM          

Co-moderators: Christopher Bowlus, MD; and Raj Vuppalanchi, MD  


Navigating the Future: Emerging Therapies and Strategic Positioning in the Management of Primary Biliary Cholangitis (PBC)

Gideon Hirschfield, MA, MB, PhD, and Aparna Goel, MD 


Debate: What Should be used as the first-line treatment for Autoimmune Hepatitis (AIH)?

Lily Dara, MD, and Craig Lammert, MD


PSC Update and Cholestatic Itch

Gideon Hirschfield, MA, MB, PhD, and Aparna Goel, MD 


Q&A/Panel Discussion

10:00 AM – 10:30 AM         



Session VI: Viral Hepatitis

10:30 AM – 12:00 PM         

Co-moderators: Ira Jacobson, MD; and Paul Martin, MD

10:30 AM – 10:55 AM

Navigating Challenges in HCV Therapy: Addressing the Issues that Remain 

Mark Sulkowski, MD 

10:55 AM – 11:20 AM

Diagnosis and Management of Hepatitis E

Kenneth Sherman, MD, PhD

11:20 AM – 11:40 AM 

Hep B Case & Panel Discussion    

Mindie Nguyen, MD, MAS    

11:40 AM – 12:00 PM 

Hep D Case & Panel Discussion 

Paul Martin, MD

12:00 PM – 12:15 PM

Conference Summary & Closing Remarks

Kimberly Brown, MD 


12:15 PM – 12:45 PM         

Lunch Break


12:45 PM – 1:30 PM           

Industry-Sponsored Event (Non-Accredited)

1:45 PM – 3:45 PM

Women in Hepatology Leadership Forum

1:45 PM – 4:50 PM  

Pediatric Connect: New Therapies and Controversies in Pediatric Liver Disease

Co-Chairs: Carina Kugelmas, MD; and Miriam Vos, MD, MSPH




Co-Chairs: Carina Kugelmas, MD and Miriam Vos, MD, MSPH

1:45 – 1:50 PM

Welcome and Introduction

1:50 PM – 2:30 PM

Session I: Cholestatic Liver Disease in Early Childhood

Co-Moderators: Rohit Kohli, MD; and Miriam Vos, MD, MSPH

1:50 – 2:05 PM

Clinical Advances in Biliary Atresia

Ronald Sokol, MD

2:05 – 2:15 PM

Pro/Con: Treatment Regimens – Steroids

Pro: Anna Peters, MD

Con: Speaker TBD

2:15 – 2:30 PM

News in PFIC and Alagille Syndrome: How New Drugs Change Treatment

Binita Kamath, MD


2:30 – 2:50 PM

Panel Discussion & Cases

Udeme Ekong, MD; Binita Kamath, MD; Anna Peters, MD; and Ronald Sokol, MD

2:50 – 3:05 PM


3:05 PM – 4:25 PM

Session II: Chronic Liver Disease in Adolescents

Moderator: Ronald Sokol, MD

3:05 – 3:20 PM

Diagnostic and Treatment Challenges in AIH

Nitika Gupta, MD

3:20 - 3:35 PM

Diagnostic and Treatment Dilemmas in PSC and Overlap

Mark Deneau, MD

3:35 – 3:55 PM

Panel Discussion: AIH Cases and Dilemmas

Mark Deneau, MD; Udeme Ekong, MD; Nitika Gupta, MD; and Mercedes Martinez, MD

Moderators: Julie Bonn, MD; and Jay Freeman, MD

3:55 – 4:10 PM

CF Associated Liver Disease – Best Screening Practices

Dan Leung, MD


4:10 – 4:25 PM

Diagnostic Dilemmas and New Medications in Wilson’s Disease

Regino Gonzalez-Peralta, MD

4:25 – 4:45 PM

Panel Discussion: CF and Wilson's Cases

Rima Fawez, MD; Regino Gonzalez-Peralta, MD; Nitika Gupta, MD; and Dan Leung, MD

4:45 – 4:50 PM

Closing Remarks

bottom of page